Dash Bio

BiotechnologySeries ABoston, USdash.bio

Latest round

Series A

Last raised

Jun 2026

Total raised

$47M

Investors

7

About Dash Bio

Established in 2024 by co-founder Dave Johnson (CEO), and Ander Tallett and based in Massachusetts, US, Dash Bio, Inc. provides bioinformatics solutions that enable AI-driven and robotics-supported drug development. June 2026, Dash Bio, Inc. Dash Bio, Inc. specializes in advanced bioanalysis through its automated platform designed to enhance the efficiency and quality of clinical studies. The company’s core offerings include assay development, validation, and comprehensive sample analysis tailored for in vivo and clinical studies, which allow for the rapid execution of essential assays. With a commitment to data-driven outcomes, Dash Bio's services cater to pharmaceutical and biotechnology companies that require precise and timely bioanalytical support to accelerate their drug development processes.

Who invested in Dash Bio

7 investors across 3 rounds

See all investors in Dash Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 15, 2026

    Amount

    $30M

    Investors

    Locked

  2. Seed

    Jun 13, 2025

    Amount

    $11M

    Investors

    Locked

  3. Seed

    Oct 2, 2024

    Amount

    $6.1M

    Investors

    Locked

Questions about Dash Bio

Who invested in Dash Bio?

Dash Bio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dash Bio raised?

Dash Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Dash Bio last raise money?

Dash Bio's most recent round on record is a Series A, in Jun 2026.

What does Dash Bio do?

Established in 2024 by co-founder Dave Johnson (CEO), and Ander Tallett and based in Massachusetts, US, Dash Bio, Inc.

Where is Dash Bio headquartered?

Dash Bio is headquartered in Boston, US.

Which VCs invest in companies like Dash Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dash Bio's stage. Their profiles are linked below.

Raising like Dash Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.